Iris-Melanie Noebauer-Huhmann,Filip M. Vanhoenacker,Joan C. Vilanova,Alberto S. Tagliafico,Marc-André Weber,Radhesh K. Lalam,Thomas Grieser,Violeta Vasilevska Nikodinovska,Jacky W. J. de Rooy,Olympia Papakonstantinou,Catherine Mccarthy,Luca Maria Sconfienza,Koenraad Verstraete,José Martel-Villagrán,Pavol Szomolanyi,Frédéric E. Lecouvet,Diana Afonso,Omar M. Albtoush,Giacomo Aringhieri,Remide Arkun,Gunnar Aström,Alberto Bazzocchi,Rajesh Botchu,Martin Breitenseher,Snehansh Chaudhary,Danoob Dalili,Mark Davies,Milko C. de Jonge,Berna D. Mete,Jan Fritz,Jan L. M. A. Gielen,Geoff Hide,Amanda Isaac,Slavcho Ivanoski,Ramy M. Mansour,Lorenzo Muntaner-Gimbernat,Ana Navas,Paul O´Donnell,Şebnem Örgüç,Winston Rennie,Santiago Resano,Philip Robinson,Hatice T. Sanal,Simone A. J. Ter Horst,Kirsten van Langevelde,Klaus Wörtler,Marita Koelz,Joannis Panotopoulos,Reinhard Windhager,Johannes L. Bloem

Abstract:Abstract Objectives Early, accurate diagnosis is crucial for the prognosis of patients with soft tissue sarcomas. To this end, standardization of imaging algorithms, technical requirements, and reporting is therefore a prerequisite. Since the first European Society of Musculoskeletal Radiology (ESSR) consensus in 2015, technical achievements, further insights into specific entities, and the revised WHO-classification (2020) and AJCC staging system (2017) made an update necessary. The guidelines are intended to support radiologists in their decision-making and contribute to interdisciplinary tumor board discussions. Materials and methods A validated Delphi method based on peer-reviewed literature was used to derive consensus among a panel of 46 specialized musculoskeletal radiologists from 12 European countries. Statements were scored online by level of agreement (0 to 10) during two iterative rounds. Either “group consensus,” “group agreement,” or “lack of agreement” was achieved. Results Eight sections were defined that finally contained 145 statements with comments. Overall, group consensus was reached in 95.9%, and group agreement in 4.1%. This communication contains the first part consisting of the imaging algorithm for suspected soft tissue tumors, methods for local imaging, and the role of tumor centers. Conclusion Ultrasound represents the initial triage imaging modality for accessible and small tumors. MRI is the modality of choice for the characterization and local staging of most soft tissue tumors. CT is indicated in special situations. In suspicious or likely malignant tumors, a specialist tumor center should be contacted for referral or teleradiologic second opinion. This should be done before performing a biopsy, without exception. Clinical relevance The updated ESSR soft tissue tumor imaging guidelines aim to provide best practice expert consensus for standardized imaging, to support radiologists in their decision-making, and to improve examination comparability both in individual patients and in future studies on individualized strategies. Key Points • Ultrasound remains the best initial triage imaging modality for accessible and small suspected soft tissue tumors. • MRI is the modality of choice for the characterization and local staging of soft tissue tumors in most cases; CT is indicated in special situations. Suspicious or likely malignant tumors should undergo biopsy. • In patients with large, indeterminate or suspicious tumors, a tumor reference center should be contacted for referral or teleradiologic second opinion; this must be done before a biopsy.

Conformal radiotherapy in management of soft tissue sarcoma in adults

[Rôle of radiotherapy for sarcomas]

Soft tissue sarcomas: radiation as a therapeutic option

Management of oligometastatic/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches

Update on Dosing and Fractionation for Neoadjuvant Radiotherapy for Localized Soft Tissue Sarcoma

PET/CT and PET/MR in Soft Tissue Sarcoma: An Update

Radiotherapy versus limb‐sparing surgery alone in low‐grade soft‐tissue sarcoma of the extremity and trunk wall: a systematic review and meta‐analysis

Preoperative sequential chemotherapy and hypofractionated radiotherapy combined with comprehensive surgical resection for high-risk soft tissue sarcomas: a retrospective study

The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma

UK guidelines for the management of soft tissue sarcomas

Compliance with National Comprehensive Cancer Network guidelines in the use of radiation therapy for extremity and superficial trunk soft tissue sarcoma in the United States

Histology-Tailored Approach to Soft Tissue Sarcoma

Soft tissue tumor imaging in adults: whole-body staging in sarcoma, non-malignant entities requiring special algorithms, pitfalls and special imaging aspects. Guidelines 2024 from the European Society of Musculoskeletal Radiology (ESSR)

Unraveling the Myth of Radiation Resistance in Soft Tissue Sarcomas

Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2023—overview, and primary local imaging: how and where?

The role of radiotherapy in multimodal treatment of non-rhabdomyosarcoma soft tissue sarcomas in children: A real life report from a tertiary center

Radiographic response to neoadjuvant therapy and its impact on scope of surgery and prognosis in stage IIB/III soft tissue sarcomas

Recent Advances in the Surgical Management of Radiation-Induced Fractures following Soft Tissue Sarcomas

Refusal of Adjuvant Therapies and Its Impact on Local Control and Survival in Patients with Bone and Soft Tissue Sarcomas of the Extremities and Trunk

Efficacy and safety of hypofractionated preoperative radiotherapy in treatment of patient with primary locally advanced soft tissue sarcoma of limbs/trunk wall.

Modern Multidisciplinary Management of Soft Tissue Sarcoma of the Extremity and Trunk